|
1
|
Banaudha KK and Verma M: Epigenetic
biomarkers in liver cancer. Methods Mol Biol. 1238:65–76. 2015.
View Article : Google Scholar
|
|
2
|
Raza A and Sood GK: Hepatocellular
carcinoma review: Current treatment, and evidence-based medicine.
World J Gastroenterol. 20:4115–4127. 2014. View Article : Google Scholar
|
|
3
|
Reig M, Mariño Z, Perelló C, Iñarrairaegui
M, Ribeiro A, Lens S, Díaz A, Vilana R, Darnell A, Varela M, et al:
Unexpected high rate of early tumor recurrence in patients with
HCV-related HCC undergoing interferon-free therapy. J Hepatol.
65:719–726. 2016. View Article : Google Scholar
|
|
4
|
Jarroux J, Morillon A and Pinskaya M:
History, discovery, and classification of lncRNAs. Adv Exp Med
Biol. 1008:1–46. 2017. View Article : Google Scholar
|
|
5
|
Kim S, Jeong H, Kim EY, Kim JF, Lee SY and
Yoon SH: Genomic and transcriptomic landscape of Escherichia coli
BL21(DE3). Nucleic Acids Res. 45:5285–5293. 2017. View Article : Google Scholar
|
|
6
|
Xu J, Bai J, Zhang X, Lv Y, Gong Y, Liu L,
Zhao H, Yu F, Ping Y, Zhang G, et al: A comprehensive overview of
lncRNA annotation resources. Brief Bioinform. 18:236–249. 2017.
|
|
7
|
Tian JB, Cao L and Dong GL: Long noncoding
RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer
progression through targeting miR-873/CLDN7 axis. Eur Rev Med
Pharmacol Sci. 23:5714–5729. 2019.
|
|
8
|
Xie Q, Lin S, Zheng M, Cai Q and Tu Y:
Long noncoding RNA NEAT1 promotes the growth of cervical cancer
cells via sponging miR-9-5p. Biochem Cell Biol. 97:100–108. 2019.
View Article : Google Scholar
|
|
9
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar
|
|
10
|
Alvarez-Dominguez JR and Lodish HF:
Emerging mechanisms of long noncoding RNA function during normal
and malignant hematopoiesis. Blood. 130:1965–1975. 2017. View Article : Google Scholar
|
|
11
|
Zhu J, Fu H, Wu Y and Zheng X: Function of
lncRNAs and approaches to lncRNA-protein interactions. Sci China
Life Sci. 56:876–885. 2013. View Article : Google Scholar
|
|
12
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar
|
|
13
|
Chiu HS, Rodríguez Martínez M, Bansal M,
Subramanian A, Golub TR, Yang X, Sumazin P and Califano A:
High-throughput validation of ceRNA regulatory networks. BMC
Genomics. 18:4182017. View Article : Google Scholar
|
|
14
|
Sun Q, Li J, Li F, Li H, Bei S, Zhang X
and Feng L: lncRNA LOXL1-AS1 facilitates the tumorigenesis and
stemness of gastric carcinoma via regulation of miR-708-5p/USF1
pathway. Cell Prolif. 52:e126872019. View Article : Google Scholar
|
|
15
|
Yao N, Fu Y, Chen L, Liu Z, He J, Zhu Y,
Xia T and Wang S: Long non-coding RNA NONHSAT101069 promotes
epirubicin resistance, migration, and invasion of breast cancer
cells through NONHSAT101069/miR-129-5p/Twist1 axis. Oncogene.
38:7216–7233. 2019. View Article : Google Scholar
|
|
16
|
Wojczakowski W, Kobylarek D, Lindner J,
Limphaibool N and Kaczmarek M: MicroRNAs-novel biomarkers for
malignant pleural effusions. Contemp Oncol (Pozn). 23:133–140.
2019.
|
|
17
|
Chhatriya B, Mukherjee M, Ray S, Sarkar P,
Chatterjee S, Nath D, Das K and Goswami S: Comparison of tumour and
serum specific microRNA changes dissecting their role in pancreatic
ductal adenocarcinoma: A meta-analysis. BMC Cancer. 19:11752019.
View Article : Google Scholar
|
|
18
|
Liu X and Cui M: miRNA-98-5p inhibits the
progression of osteosarcoma by regulating cell cycle via targeting
CDC25A expression. Eur Rev Med Pharmacol Sci. 23:9793–9802.
2019.
|
|
19
|
Yang T, Tian S, Wang L, Wang Y and Zhao J:
MicroRNA-367-3p overexpression represses the proliferation and
invasion of cervical cancer cells through downregulation of
SPAG5-mediated Wnt/β-catenin signaling. Clin Exp Pharmacol Physiol.
47:687–695. 2019. View Article : Google Scholar
|
|
20
|
Chen DH, Wu QW, Li XD, Wang SJ and Zhang
ZM: SYPL1 overexpression predicts poor prognosis of hepatocellular
carcinoma and associates with epithelial-mesenchymal transition.
Oncol Rep. 38:1533–1542. 2017. View Article : Google Scholar
|
|
21
|
Zhao ZB, Chen F and Bai XF: Long noncoding
RNA MALAT1 regulates hepatocellular carcinoma growth under hypoxia
via sponging microRNA-200a. Yonsei Med J. 60:727–734. 2019.
View Article : Google Scholar
|
|
22
|
Liang R, Lin Y, Ye JZ, Yan XX, Liu ZH, Li
YQ, Luo XL and Ye HH: High expression of RBM8A predicts poor
patient prognosis and promotes tumor progression in hepatocellular
carcinoma. Oncol Rep. 37:2167–2176. 2017. View Article : Google Scholar
|
|
23
|
Xiao J, Lv Y, Jin F, Liu Y, Ma Y, Xiong Y,
Liu L, Zhang S, Sun Y, Tipoe GL, et al: lncRNA HANR promotes
tumorigenesis and increase of chemoresistance in hepatocellular
carcinoma. Cell Physiol Biochem. 43:1926–1938. 2017. View Article : Google Scholar
|
|
24
|
Huang X, Gao Y, Qin J and Lu S: lncRNA
MIAT promotes proliferation and invasion of HCC cells via sponging
miR-214. Am J Physiol Gastrointest Liver Physiol. 314:G559–G565.
2018. View Article : Google Scholar
|
|
25
|
Xu F, Zha G, Wu Y, Cai W and Ao J:
Overexpressing lncRNA SNHG16 inhibited HCC proliferation and
chemoresistance by functionally sponging hsa-miR-93. Onco Targets
Ther. 11:8855–8863. 2018. View Article : Google Scholar
|
|
26
|
Rui X, Xu Y, Jiang X, Ye W, Huang Y and
Jiang J: Long non-coding RNA C5orf66-AS1 promotes cell
proliferation in cervical cancer by targeting miR-637/RING1 axis.
Cell Death Dis. 9:11752018. View Article : Google Scholar
|
|
27
|
Wu F, Gao H, Liu K, Gao B, Ren H, Li Z and
Liu F: The lncRNA ZEB2-AS1 is upregulated in gastric cancer and
affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
Onco Targets Ther. 12:657–667. 2019. View Article : Google Scholar
|
|
28
|
Tatum JL, Kelloff GJ, Gillies RJ, Arbeit
JM, Brown JM, Chao KSC, Chapman JD, Eckelman WC, Fyles AW, Giaccia
AJ, et al: Hypoxia: Importance in tumor biology, noninvasive
measurement by imaging, and value of its measurement in the
management of cancer therapy. Int J Radiat Biol. 82:699–757. 2006.
View Article : Google Scholar
|
|
29
|
Zhang X, Hamblin MH and Yin KJ: The long
noncoding RNA Malat1: Its physiological and pathophysiological
functions. RNA Biol. 14:1705–1714. 2017. View Article : Google Scholar
|
|
30
|
Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X,
Wang M, Huang C, Wang L, Zeng F and Jiang G: lncRNA SPRY4-IT1
sponges miR-101-3p to promote proliferation and metastasis of
bladder cancer cells through up-regulating EZH2. Cancer Lett.
388:281–291. 2017. View Article : Google Scholar
|
|
31
|
Gan L, Lv L and Liao S: Long noncoding RNA
H19 regulates cell growth and metastasis via the miR223p/Snail1
axis in gastric cancer. Int J Oncol. 54:2157–2168. 2019.
|
|
32
|
Shelton SB, Shah NM, Abell NS, Devanathan
SK, Mercado M and Xhemalçe B: Crosstalk between the RNA methylation
and histone-binding activities of MePCE regulates P-TEFb activation
on chromatin. Cell Rep. 22:1374–1383. 2018. View Article : Google Scholar
|
|
33
|
Liu R, Wang X, Chen GY, Dalerba P, Gurney
A, Hoey T, Sherlock G, Lewicki J, Shedden K and Clarke MF: The
prognostic role of a gene signature from tumorigenic breast-cancer
cells. N Engl J Med. 356:217–226. 2007. View Article : Google Scholar
|
|
34
|
Yao L, Chi Y, Hu X, Li S, Qiao F, Wu J and
Shao ZM: Elevated expression of RNA methyltransferase BCDIN3D
predicts poor prognosis in breast cancer. Oncotarget.
7:53895–53902. 2016. View Article : Google Scholar
|
